Medicenna Therapeutics Corp (NASDAQ:MDNA)
| 0.29 Delayed Data As of Sep 29 |  +0.011 / +3.94%Today’s Change | 0.25 Today|||52-Week Range 0.95 | -36.68% Year-to-Date |
Latest MDNA News | Press Releases
No recent news for Medicenna Therapeutics Corp.
Today’s Trading
| Previous close | 0.28 |
| Today’s open | 0.28 |
| Day’s range | 0.28 - 0.29 |
| Volume | 19,516 |
| Average volume (3 months) | 187,089 |
| Market cap | $19.6M |
Data as of 3:55pm ET, 09/29/2023
Growth & Valuation
| Earnings growth (last year) | +64.64% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.90 |
Competitors
Data as of 3:59pm ET, 09/29/2023
Financials
| Next reporting date | November 10, 2023 |
| EPS forecast (this quarter) | -$0.05 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$7.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Toronto, Ontario |
Forecasts
